{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:19:58Z","timestamp":1792153198965,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Institute Grant funded by the Catholic University of Korea Daejeon St. Mary\u2019s Hospital","award":["CMCDJ-P-2024-006"],"award-info":[{"award-number":["CMCDJ-P-2024-006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"DOI":"10.1007\/s12017-025-08895-5","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:00:56Z","timestamp":1771484456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To the GPX4\/ACSL4\/5-LOX Pathway"],"prefix":"10.1007","volume":"28","author":[{"given":"Yu Jin","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eungseok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"47","key":"8895_CR1","doi-asserted-by":"publisher","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","volume":"290","author":"L Chen","year":"2015","unstructured":"Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015). Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. The Journal of Biological Chemistry, 290(47), 28097\u201328106. https:\/\/doi.org\/10.1074\/jbc.M115.680090","journal-title":"The Journal of Biological Chemistry"},{"key":"8895_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2019.06.024","volume":"141","author":"B Chen","year":"2019","unstructured":"Chen, B., Wen, X., Jiang, H., Wang, J., Song, N., & Xie, J. (2019). Interactions between iron and \u03b1-synuclein pathology in parkinson\u2019s disease. Free Radical Biology & Medicine, 141, 253\u2013260. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.06.024","journal-title":"Free Radical Biology & Medicine"},{"issue":"5","key":"8895_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/s1734-1140(12)70914-3","volume":"64","author":"GA Czapski","year":"2012","unstructured":"Czapski, G. A., Czubowicz, K., & Strosznajder, R. P. (2012). Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacological Reports, 64(5), 1179\u20131188. https:\/\/doi.org\/10.1016\/s1734-1140(12)70914-3","journal-title":"Pharmacological Reports"},{"issue":"5","key":"8895_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., & Stockwell, B. R. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"1","key":"8895_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., Prokisch, H., Tr\u00fcmbach, D., Mao, G., Qu, F., Bayir, H., F\u00fcllekrug, J., Scheel, C. H., Wurst, W., Schick, J. A., Kagan, V. E., Angeli, J. P., & Conrad, M. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13(1), 91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nature Chemical Biology"},{"key":"8895_CR6","doi-asserted-by":"publisher","first-page":"101789","DOI":"10.1016\/j.redox.2020.101789","volume":"38","author":"C Fern\u00e1ndez-Mend\u00edvil","year":"2021","unstructured":"Fern\u00e1ndez-Mend\u00edvil, C., Luengo, E., Trigo-Alonso, P., Garc\u00eda-Magro, N., Negredo, P., & L\u00f3pez, M. G. (2021). Protective role of microglial HO-1 Blockade in aging: Implication of iron metabolism. Redox Biology, 38, 101789. https:\/\/doi.org\/10.1016\/j.redox.2020.101789","journal-title":"Redox Biology"},{"issue":"7324","key":"8895_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nature09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010). Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature, 468(7324), 696\u2013700. https:\/\/doi.org\/10.1038\/nature09536","journal-title":"Nature"},{"issue":"1","key":"8895_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.redox.2013.07.006","volume":"1","author":"E Ho","year":"2013","unstructured":"Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013). Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biology, 1(1), 483\u2013491. https:\/\/doi.org\/10.1016\/j.redox.2013.07.006","journal-title":"Redox Biology"},{"issue":"6","key":"8895_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003). Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathologica, 106(6), 518\u2013526. https:\/\/doi.org\/10.1007\/s00401-003-0766-2","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"8895_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/wnr.0000000000000740","volume":"28","author":"H Jang","year":"2017","unstructured":"Jang, H., Kim, S., Lee, J. M., Oh, Y. S., Park, S. M., & Kim, S. R. (2017). Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of parkinson\u2019s disease. Neuroreport, 28(5), 242\u2013249. https:\/\/doi.org\/10.1097\/wnr.0000000000000740","journal-title":"Neuroreport"},{"issue":"8","key":"8895_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic, J., & Tan, E. K. (2020). Parkinson\u2019s disease: Etiopathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 91(8), 795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"8895_CR12","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1016\/j.csbj.2022.09.018","volume":"20","author":"X Jian","year":"2022","unstructured":"Jian, X., Zhao, G., Chen, H., Wang, Y., Li, J., Xie, L., & Li, B. (2022). Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson\u2019s disease. Computational and Structural Biotechnology Journal, 20, 5218\u20135225. https:\/\/doi.org\/10.1016\/j.csbj.2022.09.018","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"8895_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022). The role of Cystine\/Glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Frontiers in Oncology, 12, Article 858462. https:\/\/doi.org\/10.3389\/fonc.2022.858462","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"8895_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J., Cao, F., Yin, H. L., Huang, Z. J., Lin, Z. T., Mao, N., Sun, B., & Wang, G. (2020). Ferroptosis: Past, present and future. Cell Death & Disease, 11(2), Article 88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death & Disease"},{"key":"8895_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05257-x","author":"T Li","year":"2025","unstructured":"Li, T., Liu, J., Huang, X., Xie, Y., Hu, Y., Xu, Q., Tang, B., Tan, J., & Guo, J. (2025). Deficiency of PLA2G6 induces ferroptosis in dopaminergic neurons and contributes to parkinson\u2019s disease pathogenesis via disruption of PRDX6\/FTH1\/GPX4 axis. Molecular Neurobiology. https:\/\/doi.org\/10.1007\/s12035-025-05257-x","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"8895_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1248\/bpb.b15-00048","volume":"38","author":"Y Liu","year":"2015","unstructured":"Liu, Y., Wang, W., Li, Y., Xiao, Y., Cheng, J., & Jia, J. (2015). The 5-lipoxygenase inhibitor Zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis. Biological & Pharmaceutical Bulletin, 38(8), 1234\u20131239. https:\/\/doi.org\/10.1248\/bpb.b15-00048","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"8895_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.taap.2018.09.012","volume":"358","author":"RM Mansour","year":"2018","unstructured":"Mansour, R. M., Ahmed, M. A. E., El-Sahar, A. E., & El Sayed, N. S. (2018). Montelukast attenuates rotenone-induced microglial activation\/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicology and Applied Pharmacology, 358, 76\u201385. https:\/\/doi.org\/10.1016\/j.taap.2018.09.012","journal-title":"Toxicology and Applied Pharmacology"},{"key":"8895_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091039","author":"CF Marques","year":"2022","unstructured":"Marques, C. F., Marques, M. M., & Justino, G. C. (2022). Leukotrienes vs. montelukast-Activity, metabolism, and toxicity hints for repurposing. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph15091039","journal-title":"Pharmaceuticals"},{"issue":"1","key":"8895_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9466","volume":"6","author":"J Marschallinger","year":"2015","unstructured":"Marschallinger, J., Sch\u00e4ffner, I., Klein, B., Gelfert, R., Rivera, F. J., Illes, S., Grassner, L., Janssen, M., Rotheneichner, P., Schmuckermair, C., Coras, R., Boccazzi, M., Chishty, M., Lagler, F. B., Renic, M., Bauer, H.-C., Singewald, N., Bl\u00fcmcke, I., Bogdahn, U., \u2026 Aigner, L. (2015). Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nature Communications, 6(1), Article 8466. https:\/\/doi.org\/10.1038\/ncomms9466","journal-title":"Nature Communications"},{"key":"8895_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","volume":"133","author":"S Masaldan","year":"2019","unstructured":"Masaldan, S., Bush, A. I., Devos, D., Rolland, A. S., & Moreau, C. (2019). Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology & Medicine, 133, 221\u2013233. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.033","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"8895_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.drudis.2018.09.008","volume":"24","author":"J Michael","year":"2019","unstructured":"Michael, J., Marschallinger, J., & Aigner, L. (2019). The leukotriene signaling pathway: A druggable target in Alzheimer\u2019s disease. Drug Discovery Today, 24(2), 505\u2013516. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.008","journal-title":"Drug Discovery Today"},{"issue":"1","key":"8895_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-00989-4","volume":"8","author":"J Michael","year":"2020","unstructured":"Michael, J., Unger, M. S., Poupardin, R., Schernthaner, P., Mrowetz, H., Attems, J., & Aigner, L. (2020). Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s disease mice. Acta Neuropathologica Communications, 8(1), Article 129. https:\/\/doi.org\/10.1186\/s40478-020-00989-4","journal-title":"Acta Neuropathologica Communications"},{"key":"8895_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2018.05.052","volume":"682","author":"VB Nagarajan","year":"2018","unstructured":"Nagarajan, V. B., & Marathe, P. A. (2018). Effect of Montelukast in experimental model of Parkinson\u2019s disease. Neuroscience Letters, 682, 100\u2013105. https:\/\/doi.org\/10.1016\/j.neulet.2018.05.052","journal-title":"Neuroscience Letters"},{"issue":"14","key":"8895_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer\u2019s disease and Parkinson\u2019s disease. The New England Journal of Medicine, 348(14), 1356\u20131364. https:\/\/doi.org\/10.1056\/NEJM2003ra020003","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"8895_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.bbrc.2004.09.125","volume":"324","author":"R Ramires","year":"2004","unstructured":"Ramires, R., Caiaffa, M. F., Tursi, A., Haeggstr\u00f6m, J. Z., & Macchia, L. (2004). Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug Montelukast. Biochemical and Biophysical Research Communications, 324(2), 815\u2013821. https:\/\/doi.org\/10.1016\/j.bbrc.2004.09.125","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"10","key":"8895_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00702-021-02414-z","volume":"128","author":"P Riederer","year":"2021","unstructured":"Riederer, P., Monoranu, C., Strobel, S., Iordache, T., & Sian-H\u00fclsmann, J. (2021). Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson\u2019s disease. Journal Of Neural Transmission, 128(10), 1577\u20131598. https:\/\/doi.org\/10.1007\/s00702-021-02414-z","journal-title":"Journal Of Neural Transmission"},{"issue":"3","key":"8895_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah, R., Shchepinov, M. S., & Pratt, D. A. (2018). Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Central Science, 4(3), 387\u2013396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589","journal-title":"ACS Central Science"},{"issue":"5","key":"8895_CR28","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1007\/s12035-015-9267-2","volume":"53","author":"N Sharma","year":"2016","unstructured":"Sharma, N., & Nehru, B. (2016). Apocyanin, a microglial NADPH oxidase inhibitor prevents dopaminergic neuronal degeneration in lipopolysaccharide-induced parkinson\u2019s disease model. Molecular Neurobiology, 53(5), 3326\u20133337. https:\/\/doi.org\/10.1007\/s12035-015-9267-2","journal-title":"Molecular Neurobiology"},{"issue":"5","key":"8895_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102431","volume":"24","author":"LM Song","year":"2021","unstructured":"Song, L. M., Xiao, Z. X., Zhang, N., Yu, X. Q., Cui, W., Xie, J. X., & Xu, H. M. (2021). Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis. IScience, 24(5), Article 102431. https:\/\/doi.org\/10.1016\/j.isci.2021.102431","journal-title":"IScience"},{"key":"8895_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1390798","volume":"15","author":"P Soni","year":"2024","unstructured":"Soni, P., Ammal Kaidery, N., Sharma, S. M., Gazaryan, I., Nikulin, S. V., Hushpulian, D. M., & Thomas, B. (2024). A critical appraisal of ferroptosis in Alzheimer\u2019s and Parkinson\u2019s disease: New insights into emerging mechanisms and therapeutic targets. Frontiers in Pharmacology, 15, Article 1390798. https:\/\/doi.org\/10.3389\/fphar.2024.1390798","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"8895_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1073\/pnas.0709737104","volume":"105","author":"E Soupene","year":"2008","unstructured":"Soupene, E., Fyrst, H., & Kuypers, F. A. (2008). Mammalian acyl-CoA: Lysophosphatidylcholine acyltransferase enzymes. Proceedings of the National Academy of Sciences, 105(1), 88\u201393. https:\/\/doi.org\/10.1073\/pnas.0709737104","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"8895_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"ZL Wang","year":"2022","unstructured":"Wang, Z. L., Yuan, L., Li, W., & Li, J. Y. (2022). Ferroptosis in Parkinson\u2019s disease: Glia-neuron crosstalk. Trends in Molecular Medicine, 28(4), 258\u2013269. https:\/\/doi.org\/10.1016\/j.molmed.2022.02.003","journal-title":"Trends in Molecular Medicine"},{"issue":"34","key":"8895_CR33","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B. R. (2016). Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proceedings of the National Academy of Sciences of the United States of America, 113(34), E4966\u20134975. https:\/\/doi.org\/10.1073\/pnas.1603244113","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8895_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102063","volume":"91","author":"K Yang","year":"2023","unstructured":"Yang, K., Zeng, L., Zeng, J., Deng, Y., Wang, S., Xu, H., He, Q., Yuan, M., Luo, Y., Ge, A., & Ge, J. (2023). Research progress in the molecular mechanism of ferroptosis in Parkinson\u2019s disease and regulation by natural plant products. Ageing Research Reviews, Article 102063. https:\/\/doi.org\/10.1016\/j.arr.2023.102063","journal-title":"Ageing Research Reviews"},{"issue":"4","key":"8895_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/aps.2016.162","volume":"38","author":"S Zhao","year":"2017","unstructured":"Zhao, S., Ma, L., Chu, Z., Xu, H., Wu, W., & Liu, F. (2017). Regulation of microglial activation in stroke. Acta Pharmacologica Sinica, 38(4), 445\u2013458. https:\/\/doi.org\/10.1038\/aps.2016.162","journal-title":"Acta Pharmacologica Sinica"},{"key":"8895_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2017.01.003","volume":"36","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y., Wang, B., Tao, K., Yang, H., Wang, Y., Zhou, T., Yang, Y., Yuan, L., Liu, X., & Duan, Y. (2017). Iron accumulation and microglia activation contribute to substantia Nigra hyperechogenicity in the 6-OHDA-induced rat model of parkinson\u2019s disease. Parkinsonism & Related Disorders, 36, 76\u201382. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.01.003","journal-title":"Parkinsonism & Related Disorders"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-025-08895-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-025-08895-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-025-08895-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:00:57Z","timestamp":1771484457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-025-08895-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8895"],"URL":"https:\/\/doi.org\/10.1007\/s12017-025-08895-5","relation":{},"ISSN":["1559-1174"],"issn-type":[{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}